Meet the Doc Who Put Hydroxychloroquine (and More) on Trial in COVID-19


Manage episode 311092157 series 3082824
By Medscape Podcasts. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Instead of trying therapies and hoping for the best, the RECOVERY trial investigators designed randomized trials to test which therapeutics were truly effective for COVID-19. Dr Harrington interviews lead investigator Martin Landray, MB ChB, PhD.

To read a transcript or to comment:

The Bob Harrington Show is intended for healthcare professionals.

RECOVERY Trial Website and Some Publications

Randomized Evaluation of COVID-19 Therapy

Dexamethasone in Hospitalized Patients with Covid-19

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Remdesivir for the Treatment of Covid-19 — Final Report

Dexamethasone in Hospitalized Patients with Covid-19

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Clinical Trials and Informed Consent

The good Clinical Trials Collaborative

Why do we need some large, simple randomized trials?

Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials

You may also like:

Medscape Editor-in-Chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

Questions or feedback? Please contact:

47 episodes